Summit Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History

Summit Wealth Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-110,087	Closed	–	–	243
2023 Q1	$0	Buy	+110,087	New	+$62M	﹤0.01%	252

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Summit Wealth Group's TMO Position: Q2 2023 in Review

Summit Wealth Group sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 110,087 shares.

Summit Wealth Group first reported a position in TMO in Q1 2023 and held it in 1 quarter. The position peaked at $0 in Q1 2023. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Summit Wealth Group reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
Summit Wealth Group sold 110,087 Thermo Fisher Scientific shares in Q2 2023.
Summit Wealth Group first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 1 quarter.
Summit Wealth Group's Thermo Fisher Scientific position peaked at $0 in Q1 2023.
2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Summit Wealth Group's 13F filing for Q2 2023, filed 26 Jul 2023.